{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:41:50Z","timestamp":1769762510796,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,29]]},"DOI":"10.7759\/cureus.102571","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T18:00:21Z","timestamp":1769709621000},"source":"Crossref","is-referenced-by-count":0,"title":["Optimizing the Use of Serum Immunofixation for the Detection of Monoclonal Components in Hypogammaglobulinemia: Insights From a Tertiary-Care Biochemistry Laboratory"],"prefix":"10.7759","author":[{"given":"Kholoud","family":"Krimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dounia","family":"El Moujtahide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El-Houcine","family":"Sebbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Choukri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel H","year":"2008","unstructured":"Chapel H, Lucas M, Lee M, et al.. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008, 112:277-86. 10.1182\/blood-2007-11-124545","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus Document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla FA","year":"2016","unstructured":"Bonilla FA, Barlan I, Chapel H, et al.. International Consensus Document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016, 4:38-59. 10.1016\/j.jaip.2015.07.025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson G","year":"2014","unstructured":"Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014, 5:520. 10.3389\/fimmu.2014.00520","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder HW Jr","year":"2010","unstructured":"Schroeder HW Jr, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010, 125:S41-52. 10.1016\/j.jaci.2009.09.046","journal-title":"J Allergy Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00415","article-title":"Comparison of diagnostic criteria for common variable immunodeficiency disorder","volume":"5","author":"Ameratunga R","year":"2014","unstructured":"Ameratunga R, Brewerton M, Slade C, et al.. Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front Immunol. 2014, 5:415. 10.3389\/fimmu.2014.00415","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-011-1452-3","article-title":"Educational paper. The expanding clinical and immunological spectrum of severe combined immunodeficiency","volume":"170","author":"van der Burg M","year":"2011","unstructured":"van der Burg M, Gennery AR. Educational paper. The expanding clinical and immunological spectrum of severe combined immunodeficiency. Eur J Pediatr. 2011, 170:561-71. 10.1007\/s00431-011-1452-3","journal-title":"Eur J Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29438","article-title":"Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: natural history, clinical correlates, and outcomes","volume":"121","author":"Parikh SA","year":"2015","unstructured":"Parikh SA, Leis JF, Chaffee KG, et al.. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: natural history, clinical correlates, and outcomes. Cancer. 2015, 121:2883-91. 10.1002\/cncr.29438","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0388","article-title":"Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification, and management","volume":"30","author":"Yazdani R","year":"2020","unstructured":"Yazdani R, Habibi S, Sharifi L, Azizi G, Abolhassani H, Olbrich P, Aghamohammadi A. Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification, and management. J Investig Allergol Clin Immunol. 2020, 30:14-34. 10.18176\/jiaci.0388","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann B","year":"2014","unstructured":"Gathmann B, Mahlaoui N, G\u00e9rard L, et al.. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014, 134:116-26. 10.1016\/j.jaci.2013.12.1077","journal-title":"J Allergy Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti I","year":"2007","unstructured":"Quinti I, Soresina A, Spadaro G, et al.. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007, 27:308-16. 10.1007\/s10875-007-9075-1","journal-title":"J Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.02.040","article-title":"Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years","volume":"125","author":"Lucas M","year":"2010","unstructured":"Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol. 2010, 125:1354-1360.e4. 10.1016\/j.jaci.2010.02.040","journal-title":"J Allergy Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease","volume":"99","author":"Warnatz K","year":"2002","unstructured":"Warnatz K, Denz A, Dr\u00e4ger R, et al.. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002, 99:1544-51. 10.1182\/blood.v99.5.1544","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar SV","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, et al.. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014, 15:538-48. 10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235585","article-title":"Novel developments in the treatment of multiple myeloma-associated bone disease","volume":"15","author":"Johansen M","year":"2023","unstructured":"Johansen M, Levring MB, Stokbro K, et al.. Novel developments in the treatment of multiple myeloma-associated bone disease. Cancers (Basel). 2023, 15:10.3390\/cancers15235585","journal-title":"Cancers (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle RA","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002, 346:564-9. 10.1056\/NEJMoa01133202","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2009.126664","article-title":"Screening panels for detection of monoclonal gammopathies","volume":"55","author":"Katzmann JA","year":"2009","unstructured":"Katzmann JA, Kyle RA, Benson J, et al.. Screening panels for detection of monoclonal gammopathies. Clin Chem. 2009, 55:1517-22. 10.1373\/clinchem.2009.126664","journal-title":"Clin Chem"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-010-0047-9","article-title":"Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"5","author":"Kyle RA","year":"2010","unstructured":"Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Curr Hematol Malig Rep. 2010, 5:62-9. 10.1007\/s11899-010-0047-9","journal-title":"Curr Hematol Malig Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle RA","year":"2018","unstructured":"Kyle RA, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Cerhan JR, Rajkumar SV. Long-term follow-up of monoclonal gammopathy of undetermined significance. N Engl J Med. 2018, 378:241-9. 10.1056\/NEJMoa1709974","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.34","article-title":"Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey","volume":"28","author":"Landgren O","year":"2014","unstructured":"Landgren O, Graubard BI, Katzmann JA, et al.. Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey. Leukemia. 2014, 28:1537-42. 10.1038\/leu.2014.34","journal-title":"Leukemia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2011.153","article-title":"Evaluation of four commercial biuret reagent kits of serum total protein by the American Association for Clinical Chemistry reference measurement procedure","volume":"49","author":"He M","year":"2011","unstructured":"He M, Zhang J. Evaluation of four commercial biuret reagent kits of serum total protein by the American Association for Clinical Chemistry reference measurement procedure. Clin Chem Lab Med. 2011, 49:989-92. 10.1515\/CCLM.2011.153","journal-title":"Clin Chem Lab Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.662","article-title":"Immunoglobulin class-switch recombination: mechanism, regulation, and related diseases","volume":"5","author":"Liu JC","year":"2024","unstructured":"Liu JC, Zhang K, Zhang X, et al.. Immunoglobulin class-switch recombination: mechanism, regulation, and related diseases. MedComm (2020). 2024, 5:e662. 10.1002\/mco2.662","journal-title":"MedComm (2020)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-0326","article-title":"Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: Update on laboratory tests for the study of monoclonal gammopathies","volume":"61","author":"C\u00e1rdenas MC","year":"2023","unstructured":"C\u00e1rdenas MC, Garc\u00eda-Sanz R, Puig N, et al.. Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: Update on laboratory tests for the study of monoclonal gammopathies. Clin Chem Lab Med. 2023, 61:2115-30. 10.1515\/cclm-2023-0326","journal-title":"Clin Chem Lab Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2017.05.012","article-title":"Pathobiology and diagnosis of multiple myeloma","volume":"33","author":"Brigle K","year":"2017","unstructured":"Brigle K, Rogers B. Pathobiology and diagnosis of multiple myeloma. Semin Oncol Nurs. 2017, 33:225-36. 10.1016\/j.soncn.2017.05.012","journal-title":"Semin Oncol Nurs"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren O","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, et al.. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009, 113:5412-7. 10.1182\/blood-2008-12-194241","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12485","article-title":"Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease","volume":"179","author":"Jolles S","year":"2015","unstructured":"Jolles S, Orange JS, Gardulf A, Stein MR, Shapiro R, Borte M, Berger M. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clin Exp Immunol. 2015, 179:146-60. 10.1111\/cei.12485","journal-title":"Clin Exp Immunol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.01.025","article-title":"Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A\u00a0Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees","volume":"149","author":"Otani IM","year":"2022","unstructured":"Otani IM, Lehman HK, Jongco AM, et al.. Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A\u00a0Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees. J Allergy Clin Immunol. 2022, 149:1525-60. 10.1016\/j.jaci.2022.01.025","journal-title":"J Allergy Clin Immunol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology","volume":"117","author":"Orange JS","year":"2006","unstructured":"Orange JS, Hossny EM, Weiler CR, et al.. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006, 117:S525-53. 10.1016\/j.jaci.2006.01.015","journal-title":"J Allergy Clin Immunol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2010.01.006","article-title":"Good's syndrome remains a mystery after 55 years: a systematic review of the scientific evidence","volume":"135","author":"Kelesidis T","year":"2010","unstructured":"Kelesidis T, Yang O. Good's syndrome remains a mystery after 55 years: a systematic review of the scientific evidence. Clin Immunol. 2010, 135:347-63. 10.1016\/j.clim.2010.01.006","journal-title":"Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/455264-optimizing-the-use-of-serum-immunofixation-for-the-detection-of-monoclonal-components-in-hypogammaglobulinemia-insights-from-a-tertiary-care-biochemistry-laboratory","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T18:00:21Z","timestamp":1769709621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/455264-optimizing-the-use-of-serum-immunofixation-for-the-detection-of-monoclonal-components-in-hypogammaglobulinemia-insights-from-a-tertiary-care-biochemistry-laboratory"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.102571","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,29]]}}}